Baker Avenue Asset Management, LP Gilead Sciences, Inc. Transaction History
Baker Avenue Asset Management, LP
- $5.03 Billion
- Q3 2025
A detailed history of Baker Avenue Asset Management, LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Baker Avenue Asset Management, LP holds 3,100 shares of GILD stock, worth $384,679. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,100
Previous 2,855
8.58%
Holding current value
$384,679
Previous $316,000
8.86%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding GILD
# of Institutions
2,414Shares Held
1.01BCall Options Held
8.51MPut Options Held
7.32M-
Vanguard Group Inc Valley Forge, PA121MShares$15 Billion0.23% of portfolio
-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...